Aller au contenu

Current unmet needs in locally advanced (unresectable) or metastatic dedifferentiated liposarcoma, the relevance of progression-free survival as clinical endpoint, and expectations for future clinical trial design: an international Delphi consensus report.

Nom du journal : ESMO Open

Année : 2024

Volume : 9

Page de départ : 103487

Auteurs: Schöffski, P, Jones, RL, Agulnik, M, Blay, JY, Chalmers, A, Italiano, A & al,